Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

97thpctl

Volume

0.94×avg

Market Cap

60.83MUSD

P/E Ratio

-0.8TTM

Div Yield

-ann

Continue with finqOS

Explore Achilles Therapeutics plc's financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Achilles Therapeutics plc

ACHLNASDAQ Global Select·USD·Closed

Achilles Therapeutics plc

ACHLNASDAQ·USD·Closed

$1.48

+0.68%

$1.48

+$0.01 (0.68%)

52W Range

97thpctl

Volume

0.94×avg

Mkt Cap

60.83MUSD

P/E

-0.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

ACHL: Achilles Therapeutics plc Financial Statements & Revenue | finqOS